Increasing Access to Medication-Assisted Treatment (MAT) in Rural Primary Care Practices (R18) | Agency for Healthcare Research & Quality

Increasing Access to Medication-Assisted Treatment (MAT) in Rural Primary Care Practices (R18) | Agency for Healthcare Research & Quality

Available Now: Resources for Grant Applicants Seeking To Address Opioid Abuse Disorder in Rural Areas

Technical assistance materials are available prior to Friday’s March 4 deadline for applicants who seek AHRQ grants to address opioid use disorder in rural areas. The resources -- meeting slides and atranscript from a January 13 meeting, “Increasing Access to Medication-Assisted Treatment (MAT) in Rural Primary Care Practices” -- are available to applicants who seek funding for research demonstration projects that will use MAT to address opioid use disorder. MAT is an evidence-based approach that uses Food and Drug Administration-approved medications combined with psychosocial treatments. AHRQ is making available up to $12 million to fund as many as four research demonstration projects to support implementation of MAT.

Increasing Access to Medication-Assisted Treatment (MAT) in Rural Primary Care Practices (R18)

Slide Presentation (Text Version)

On January 13, 2016, the Agency for Healthcare Research and Quality (AHRQ) held a technical assistance teleconference on the Agency's funding opportunity announcement, "Medication-Assisted Treatment (MAT) in Rural Primary Care Practices (R18)". This is the text version of the slide presentation.